POSITION STATEMENT FOR THE TREATMENT OF ADD/ADHD WITH NEUROFEEDBACK
Author: Dr. Philip Brotman

WHO IS A CANDIDATE FOR NEUROFEEDBACK THERAPY?

Anyone with a primary diagnosis of ADD or ADHD, between the ages of 7 and 45, with low average, average, or above average intelligence. Neurofeedback treatment should not be offered with co-morbidity of:



Mental Retardation Childhood Psychosis
Severe depressive or bipolar illness
Significant seizure disorder where medications interfere with learning (i.e., sedating medications)
Hyperkinesis, where multiple medications or high dosages with monotherapy have been ineffective
Learning disabilities without ADD or ADHD as a primary problem
Dysfunctional families who refuse to participate in indicated therapy


WHAT SYMPTOMS CAN BE IMPROVED WITH NEUROFEEDBACK?


Attention, focus and concentration
Task completion and organizational skills
Impulsiveness
Mild hyperactivity


WHAT ARE THE RESULTS OF TREATMENT?


Improved behavior and learning
Improvement in school grades
Increased self-esteem
Better job performance
Greater realization of innate potential
Higher intelligence test scores
Improved scores on Parent-Teacher rating scales


HOW EFFECTIVE IS THIS TREATMENT APPROACH?

When the above criteria are used to select candidates for therapy and treatment, the majority of patients completing treatment show marked improvement. The improvement is measured and validated by improvement in the results listed above and are measured by independent observers and testing, reports by teachers, parents, and other involved health care professionals.







--------------------------------------------------------------------------------

Contact Information:
Dr. Philip Brotman
Biofeedback Instrument Corporation
255 W. 98th Street
New York, N.Y. 10025
Tel. (212) 222-5665 (5667 Fax)
Email ac@inx.net

--------------------------------------------------------------------------------

Click here to return to the articles summary page.